-
A prediction of gene sequencing application areas and scale by CD Genomics
Oct 28, 2019, 03:47 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Oct 28, 2019 - The upstream of the gene sequencing industry is the supply of sequencing instruments, sequencing reagents and consumablesFull story -
BOC Sciences Upgrades Bioconjugation Service to Help Advance Targeted Drug Delivery Research
Oct 27, 2019, 21:58 PM by Michael CroftSHIRLEY, NY, UNITED STATES - Oct 22, 2019 - Targeted drug delivery is by no means easy task, but luckily bioconjugation can be of great assistanceFull story -
Creative Proteomics Provides Glycosylation Service for Lab Research
Oct 25, 2019, 02:34 AM by Michael CroftSHIRLEY, NY - Oct 25, 2019 - Since its establishment in 2004, Creative Proteomics has gradually been a leading supplier providing proteomics, glycomics, metabolomics and bioinformatics analysis servicesFull story -
Spring Bank Announces Interim Top-Line Results from the First Cohort of the Phase 2 Trial Evaluating Low-Dose Inarigivir Plus Vemlidy® in Chronic Hepatitis B Patients
Oct 24, 2019, 14:11 PM by Michael CroftHOPKINTON, MA, UNITED STATES - Oct 17, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced interim top-line results at 12 weeks from the first cohort of the ongoing Phase 2 trial evaluating the safety, efficacy and pharmacodynamics of escalating doses (50mg, 200mg and 400mg) of the investigational compound inarigivir co-administered with Gilead Sciences Vemlidy® (tenofovir alafenamide 25mg) for the treatment of chronic hepatitis B virus (HBV) infectionFull story -
The Greatest Medical Advancements Of The Future Will Originate In Data-Driven Enterprises
Oct 24, 2019, 11:30 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Combining the core competencies of life sciences and medicine with data-driven solutions will enable researchers and providers to revolutionize healthcare.
-
KCR Announces new Chief Technology Officer
Oct 24, 2019, 09:15 AM by Michael CroftBOSTON, MA, US - Oct 24, 2019 - KCR, an international clinical development solutions provider, has named Douglas Bain the organizations Chief Technology OfficerFull story -
TrialScope Acquires Clinical Trial Connect
Oct 24, 2019, 09:11 AM by Michael CroftJERSEY CITY, NJ, US - Oct 24, 2019 - TrialScope, the global leader in transparency and disclosure compliance solutions, has acquired Clinical Trial Connect, a platform used by disease foundations and advocacy groups that connects their community members to relevant clinical trialsFull story -
MR Solutions’ new preclinical imaging PET/CT range on display at EANM ‘19
Oct 24, 2019, 05:07 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Oct 24, 2019 - MR Solutions has launched a complete range of advanced PET/CT preclinical imaging systems at EANM 19, (European Association of Nuclear Medicine) last week in BarcelonaFull story -
ZEISS expands its portfolio of microscope cameras
Oct 23, 2019, 10:15 AM by Michael CroftCHICAGO, IL, UNITED STATES - Oct 23, 2019 - ZEISS introduces four new high-quality CMOS cameras for digital imaging in light microscopy. These cameras complete the portfolio of proven ZEISS Axiocam models which stand for excellent performance in demanding microscopy applicationsFull story -
New Standards, Initiatives For GA4GH
Oct 23, 2019, 06:00 AM by Michael CroftFull storyBio-IT World | The Global Alliance for Genomics and Health (GA4GH) yesterday announced the unanimous approval of five new standards to enable responsible international genomic data sharing.
-
Accumen Acquires Medical Imaging Post-Processing Company 3DR Laboratories
Oct 22, 2019, 14:42 PM by Michael CroftPHOENIX, AZ - Oct 22, 2019 - Accumen Inc., the leader in healthcare performance, today announced that it has acquired 3DR Laboratories, the largest and most respected 3D medical post-processing laboratory in the United StatesFull story -
Leading Pediatric Cancer Center Selects Petagene’s Genomic Data Compression Solutions for Informatics Infrastructure
Oct 22, 2019, 07:28 AM by Michael CroftCAMBRIDGE, UK - Oct 22, 2019 - PetaGene today announced that Princess Máxima Center for Pediatric Oncology, the largest pediatric cancer center in Europe, has chosen to use PetaGenes transparent, lossless genomic data compression software, called PetaSuite, to reduce its data storage costs while accelerating access to the dataFull story -
As Demand for RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
Oct 22, 2019, 06:28 AM by Michael CroftKING OF PRUSSIA, PA - Oct 22, 2019 - CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractorsFull story -
A New Marketplace For Machine Learning Researchers—And Citizen Scientists
Oct 22, 2019, 06:00 AM by Michael CroftFull storyBio-IT World | A nonprofit devoted to citizen science has been working with biomedical researchers at Cornell University to apply crowd power and artificial intelligence (AI) to questions neither humans nor machines could answer alone.
-
Enhancing ZEISS Celldiscoverer 7 with ZEISS LSM 900 for optical sectioning
Oct 21, 2019, 12:06 PM by Michael Croft- Oct 21, 2019 - The proven ZEISS Celldiscoverer 7 is a fully integrated high-end imaging system with various incubation and detection optionsFull story -
UKI2S Innovate Accelerator reaches entrepreneurial start-ups in all parts of the UK
Oct 21, 2019, 05:27 AM by Michael CroftLONDON, UK - Oct 21, 2019 - Sciad Newswire / The UK Innovation & Science Seed Fund (UKI2S) has celebrated the first anniversary of its UKI2S Innovate Accelerator, a joint funding initiative with Innovate UK (IUK) directed at early stage science and engineering companiesFull story -
MGI Demonstrates Success of New CoolMPS™ Sequencing Chemistry on PCR-free DNBSEQ™ Platform
Oct 18, 2019, 17:19 PM by Michael CroftHOUSTON, TX, UNITED STATES - Oct 18, 2019 - MGI, a subsidiary of global genomics leader BGI Group, said early research results from its revolutionary CoolMPS proprietary sequencing technology performed with high accuracy, reproducibility and cost effectiveness, leading the way toward more efficient and accurate Massively Parallel Sequencing (MPS)Full story -
PetaGene announces collaboration with AstraZeneca to deploy its genomic data compression software in core genomics initiative
Oct 18, 2019, 08:17 AM by Michael CroftCAMBRIDGE, UK - Oct 18, 2019 - PetaGene announced today that their PetaSuite software has been selected to compress the genomics data sets for AstraZenecas Centre for Genomics Research (CGR)Full story -
Consent and Privacy Policy Updates From GA4GH
Oct 18, 2019, 06:15 AM by Michael CroftFull storyBio-IT World | Last month the Regulatory and Ethics Work Stream of the Global Alliance for Genomics in Health shared revised regulatory and ethics policies.
-
Amplion's Machine Learning Platform Accelerates Precision Medicine Collaboration
Oct 16, 2019, 13:13 PM by Michael CroftBEND, OR, UNITED STATES - Oct 16, 2019 - - Effective partnerships between pharmaceutical companies, biotechs, academia, diagnostic companies, CROs and other players along the drug development continuum are vital to achieving the realization of precision medicine- For diagnostic and test providers in particular, identifying the right pharma partnering opportunities at the right time can be daunting, yet it's critical for gaining early traction and establishing long-term profitable relationships- Amplion's Dx:Revenue solution plays an important role in aiding test providers in finding and targeting these elusive pharma partnering opportunities through relevant and timely insightsAmplion, a leading precision medicine intelligence company, has released Dx:Revenue, a groundbreaking software solution that enables test providers to identify ideal pharmaceutical partnership opportunities at the right time to advance precision medicine collaborationFull story